John P. Butler - Net Worth and Insider Trading
John P. Butler Net Worth
The estimated net worth of John P. Butler is at least $5 Million dollars as of 2024-11-05. John P. Butler is the CEO and President of Akebia Therapeutics Inc and owns about 2,364,436 shares of Akebia Therapeutics Inc (AKBA) stock worth over $4 Million. John P. Butler is the Director of Zynerba Pharmaceuticals Inc and owns about 80,765 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $104,995. John P. Butler is also the Director of Relypsa Inc and owns about 2,849 shares of Relypsa Inc (RLYP) stock worth over $91,140. Details can be seen in John P. Butler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John P. Butler has not made any transactions after 2024-02-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John P. Butler
John P. Butler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John P. Butler owns 4 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) , Akebia Therapeutics Inc (AKBA) , and Keryx Biopharmaceuticals Inc (KERX) among others .
Click here to see the complete history of John P. Butler’s form 4 insider trades.
Insider Ownership Summary of John P. Butler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZYNE | Zynerba Pharmaceuticals Inc | 2023-06-14 | director |
| AKBA | Akebia Therapeutics Inc | 2024-02-29 | director & CEO & President |
| KERX | Keryx Biopharmaceuticals Inc | 2017-06-09 | director |
 | | 2016-09-01 | director |
John P. Butler Latest Holdings Summary
John P. Butler currently owns a total of 3 stocks. Among these stocks, John P. Butler owns 2,364,436 shares of Akebia Therapeutics Inc (AKBA) as of February 29, 2024, with a value of $4 Million and a weighting of 95.73%. John P. Butler owns 80,765 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of June 14, 2023, with a value of $104,995 and a weighting of 2.29%. John P. Butler also owns 2,849 shares of Relypsa Inc (RLYP) as of June 7, 2016, with a value of $91,140 and a weighting of 1.98%.
Latest Holdings of John P. Butler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2024-02-29 | 2,364,436 | 1.86 | 4,397,851 |
| ZYNE | Zynerba Pharmaceuticals Inc | 2023-06-14 | 80,765 | 1.30 | 104,995 |
| RLYP | Relypsa Inc | 2016-06-07 | 2,849 | 31.99 | 91,140 |
Holding Weightings of John P. Butler
John P. Butler Form 4 Trading Tracker
According to the SEC Form 4 filings, John P. Butler has made a total of 6 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 46,570 shares on February 29, 2024, which brought John P. Butler around $73,581.
According to the SEC Form 4 filings, John P. Butler has made a total of 2 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 115 shares on June 14, 2023, which brought John P. Butler around $40.
According to the SEC Form 4 filings, John P. Butler has made a total of 0 transactions in Relypsa Inc (RLYP) over the past 5 years. The most-recent trade in Relypsa Inc is the sale of 1,013 shares on June 7, 2016, which brought John P. Butler around $19,571.
Insider Trading History of John P. Butler
- 1
John P. Butler Trading Performance
GuruFocus tracks the stock performance after each of John P. Butler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John P. Butler is 93.47%. GuruFocus also compares John P. Butler's trading performance to market benchmark return within the same time period. The performance of stocks bought by John P. Butler within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John P. Butler's insider trading performs compared to the benchmark.
Performance of John P. Butler
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 60.17 | | | | | |
| Relative Return to S&P 500(%) | 57.17 | | | | | |
John P. Butler Ownership Network
Ownership Network List of John P. Butler
Ownership Network Relation of John P. Butler
John P. Butler Owned Company Details
What does Zynerba Pharmaceuticals Inc do?
Who are the key executives at Zynerba Pharmaceuticals Inc?
John P. Butler is the director of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include Chief Financial Officer James E Fickenscher , director & Chairman & Chief Exec. Officer Armando Anido , and President Terri B Sebree .
Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary
Over the past 18 months, John P. Butler made no insider transaction in Zynerba Pharmaceuticals Inc (ZYNE). Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 17,830 shares made by Armando Anido , a net sale of 12,401 shares made by Terri B Sebree , and a net sale of 8,998 shares made by James E Fickenscher .
In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 48,835 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 48,835 shares.
Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zynerba Pharmaceuticals Inc Insider Transactions
John P. Butler Mailing Address
Above is the net worth, insider trading, and ownership report for John P. Butler. You might contact John P. Butler via mailing address: C/o Relypsa, Inc., 700 Saginaw Dr., Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
